In vivo, a spirolactone (SC-26304) inhibited the effects of aldosterone on urinary K(+):Na(+) ratios and the binding of (3)Haldosterone to renal cytoplasmic and nuclear receptors. Cytoplasmic binding of (3)Haldosterone and (3)Hspirolactone (SC-26304) was similar in magnitude and involved the same set of sites. Under three sets of conditions-(i) in the intact rat, (ii) in kidney slices, and (iii) in reconstitution studies (mixing prelabeled cytoplasm with either purified renal nuclei or chromatin), (3)Hspirolactone (SC-26304) did not yield specific nuclear complexes in contrast to the reproducible generation of these complexes with (3)Haldosterone. In glycerol density gradients, cytoplasmic (3)Haldosterone receptor complexes sedimented at 8.5 S and 4 S in low concentrations of salt and at 4.5 S in high concentrations of salt. Cytoplasmic (3)Hspirolactone (SC-26304) receptor complexes sedimented at 3 S in low concentrations of salt and 4 S in high concentrations of salt. These results are discussed in terms of an allosteric model of the receptor system.
Marver et al. (Mon,) studied this question.